NOS2 and pancreatic ductal adenocarcinoma: Similarly, elevated levels of NOS2 in pancreatic ductal adenocarcinoma were related to lower survival rates, and NOS2 deficiency in genetically engineered mice led to reduced proliferation, migration and invasion [19].